Semantic Scholar uses AI to extract papers important to this topic.
Nanoparticle (NP) drug delivery systems (5−250 nm) have the potential to improve current disease therapies because of their… Expand The accidental discovery of the anticancer properties of cisplatin and its clinical introduction in the 1970s represent a major… Expand In HLH‐94, the first prospective international treatment study for hemophagocytic lymphohistiocytosis (HLH), diagnosis was based… Expand BACKGROUND
A regimen of epirubicin, cisplatin, and infused fluorouracil (ECF) improves survival among patients with incurable… Expand Nanomaterials are engineered structures with at least one dimension of 100 nanometers or less. These materials are increasingly… Expand BACKGROUND
Preoperative radiotherapy is recommended for selected patients with rectal cancer. We evaluated the addition of… Expand Proteins in the Bcl-2 family are central regulators of programmed cell death, and members that inhibit apoptosis, such as Bcl-XL… Expand Background The standard treatment for patients with diffuse large-B-cell lymphoma is cyclophosphamide, doxorubicin, vincristine… Expand Background The median survival of patients with myeloma after conventional chemotherapy is three years or less. Promising results… Expand We previously found that a polymer conjugated to the anticancer protein neocarzinostatin, named smancs, accumulated more in tumor… Expand